magazine.pharmamkt.net
PURE Bioscience Sets Fiscal 2019 Q1 Financial Results Conference Call
SAN DIEGO–(BUSINESS WIRE)–PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 13, 201…